Skip to main content

News

Greenspan defends role of derivatives

In a speech today, Alan Greenspan, chairman of the US Federal Reserve, defended the use of derivatives as hedging tools, especially credit derivatives. His comments come in the wake of Warren Buffett’s criticism of derivatives as potential “time bombs”.

Eurohypo selects Front Arena

Eurohypo, the German mortgage bank created by Deutsche Bank, Dresdner Bank and Commerzbank, has selected the Front Arena IT system to manage its interest rate derivatives, fixed-income, credit derivatives, structured products and money markets trading.

Japanese credit default swaps market turns defensive

Japan’s credit default swaps market continued to ignore the threat of war in Iraq, diplomatic tensions with North Korea and weak stock markets, but the mood in Tokyo was nevertheless bearish, and market participants were more keen to buy protection than…

Confusion over membership at WBOT continues

Dan Parker, chief executive of Atlanta-based Weather Board of Trade (WBOT), today told RiskNews that two institutions he originally named as charter members of the weather derivatives exchange never had such an agreement with the company.

Feinstein asks CFTC to investigate gas pricing manipulation

Dianne Feinstein, the Democrat senator for California, yesterday urged the Commodity Futures Trading Commission (CFTC) to work with the Federal Energy Regulatory Commission (FERC) to investigate whether there has been manipulation of the US natural gas…

Fimat Group reinforces Asian operations

Fimat Group, the brokerage arm of French bank Société Généralé, has promoted a number of its staff in the Asia-Pacific, in a move aimed at reinforcing its position in the region.

Reuters 3000Xtra offered via servers

Reuters has developed a centrally managed server farm that should allow clients to deploy its premium information and trading Reuters 3000Xtra terminals at reduced cost.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here